| Harriette Lewis, MD | |
|
555 E Hardy St, Inglewood, CA 90301-4011 | |
| (310) 673-4660 | |
| Not Available |
| Full Name | Harriette Lewis |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 555 E Hardy St, Inglewood, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093738270 | NPI | - | NPPES |
| 00G618650 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G61865 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Harriette Lewis, MD 6357 Nancy St, Los Angeles, CA 90045-1235 Ph: () - | Harriette Lewis, MD 555 E Hardy St, Inglewood, CA 90301-4011 Ph: (310) 673-4660 |
News Archive
Bariatric surgery-as a last resort when conservative interventions have failed-can improve liver disease and other obesity-related health problems in severely obese children and adolescents, according to a position paper in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
"Researchers who tested a novel type of antibiotic against multi-drug-resistant tuberculosis [MDR-TB] are reporting that nearly half of patients who got the new drug cleared the bacteria from their lung fluid in two months," according to a study published Thursday in the New England Journal of Medicine, Reuters reports.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer therapies, today announced it is expanding its therapeutic strategy to include active immunotherapies to treat various cancers. The Company will focus on establishing a therapeutic development program based on Adoptive Cell Immunotherapy.
MedAssurant Inc., a leading provider of data-driven healthcare solutions, today announced that Medicaid Health Plans of America (MHPA) has selected MedAssurant to provide advanced analytics to establish priorities and to inform best practices in healthcare delivery settings for Medicaid patients.
A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.
› Verified 1 days ago
Catherine Margaret Ross, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 E Hardy St, Inglewood, CA 90301 Phone: 310-673-4660 | |
Dr. David Joseph Kalmanson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 E Hardy St, Inglewood, CA 90301 Phone: 310-419-8636 Fax: 310-963-0403 | |
Takahi Oshita, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 N Prairie Ave, Inglewood, CA 90301 Phone: 310-674-7050 | |
Woojin Lee, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 555 E Hardy St, Inglewood, CA 90301 Phone: 310-419-8636 Fax: 310-963-0403 | |
Lawrence Liao, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 E Hardy St, Inglewood, CA 90301 Phone: 310-673-4660 | |
Dr. Sharonda Patrice Covington, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 E Hardy St, Inglewood, CA 90301 Phone: 310-419-8636 Fax: 340-963-0403 |